The Disease Burden of Hereditary Angioedema: Insights from a Survey in French-Canadians from Quebec

Figure 7

Time since the last ED visit for an HAE episode for participants (a) receiving LTP and those not receiving LTP and (b) with HAE type I/II versus HAE nC1-INH. HAE, hereditary angioedema; HAE nC1-INH, HAE with normal C1 inhibitor; LTP, long-term prophylaxis.

(a)

(b)